Eric Green said the process leading to his ouster as a NIH institute director by the Trump administration remains "shrouded ...

State workers who for decades have been pivotal in identifying U.S. cancer trends, curbing new cases, and improving screening ...

Policymakers will need to address the true drivers of high drug prices here at home, while simultaneously pressing our allies ...

As federal grants to study the use of race in clinical algorithms dry up researchers are looking for other funding sources.

Over the past few months, several op-eds and commentaries have offered solutions to keep U.S. science moving forward in the ...

In the debate over Medicaid reform, one dubious claim keeps getting tossed around. But the evidence for it is weak.

Republicans across the House and Senate are still working out significant disagreements on restrictions to provider taxes and ...

There seemed to be one question on the minds of many senators grilling Susan Monarez, President Trump’s pick to run the ...

Days after a federal judge ordered the restoration of more than 1,000 biomedical research grants, the National Institutes of ...

With health secretary Robert F. Kennedy Jr.'s explicit and implicit encouragement, medical entrepreneurs are offering pricey ...

Viking Therapeutics announced the start of Phase 3 studies involving its injectable, GLP-1/GIP-targeted obesity drug, called ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.